Our data indicate that AGGF1 can serve as a novel therapeutic agent for the treatment of critical limb ischemia as increased AGGF1 expression in skeletal muscles enhanced limb function, increased blood flow, and healed ischemic ulcers in a mouse hindlimb ischemia model. The gene discussed is AGGF1; the disease is limb ischemia.